International Clinical Trial: Diagnostic Performance of ACP3-Targeted PET Imaging in Patients With Primary and Recurrent Prostate Cancer: An Open-Label, Single-Arm, Single-Center Study

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07830212) titled 'Diagnostic Performance of ACP3-Targeted PET Imaging in Patients With Primary and Recurrent Prostate Cancer: An Open-Label, Single-Arm, Single-Center Study' on Sept. 15.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).

Primary Sponsor: Yong He

Condition: Prostatic Neoplasms Prostate Cancer

Intervention: Drug: [68Ga]Ga-OncoACP3

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: October 2026

Target Sample Size: 50

Countries of Recruitment: China

To know more, visit http...